Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

GP-Act III Acquisition (GPAT) Shares Outstanding (Weighted Average) (2023 - 2025)

GP-Act III Acquisition (GPAT) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $28.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 34.5% to $28.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.8 million through Dec 2025, up 34.5% year-over-year, with the annual reading at $28.8 million for FY2025, 34.5% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $28.8 million at GP-Act III Acquisition, roughly flat from $28.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $28.8 million in Q3 2024, with the low at $6.2 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 3 years is $15.2 million, with a median of $7.4 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Weighted Average) surged 360.0% in 2024, then fell 5.73% in 2025.
  • GP-Act III Acquisition's Shares Outstanding (Weighted Average) stood at $6.2 million in 2023, then skyrocketed by 242.0% to $21.4 million in 2024, then skyrocketed by 34.5% to $28.8 million in 2025.
  • Per Business Quant, the three most recent readings for GPAT's Shares Outstanding (Weighted Average) are $28.8 million (Q4 2025), $28.8 million (Q3 2025), and $7.2 million (Q2 2025).